Jean Jacques Fournié, PhD

Jean Jacques Fournié, PhD completed his PhD (Biochemistry and Immunology) from Toulouse University and Post-doctoral studies at the Clinical Immunology Research Center of University of Sydney, Australia. He was a founder of Innate Pharma, a company developing NK cell therapies for cancer. Dr. Fournié is also the Founding Director of Cancer Research Center of Toulouse, an international cancer research laboratory from INSERM, University of Toulouse 3 and CNRS, and leads the research team ‘Innovating Therapeutics Strategies in Lymphomas’ of Laboratoire d’Excellence Toulouse Cancer at Institut Universitaire du Cancer of Toulouse-Oncopole, France. He published more than 150 papers in high level journals and authored 21 patents.

AGT on Social Media: